Published in Cancer Weekly, September 12th, 2000
"We describe a potential therapeutic use for a pituitary specific replication competent adenovirus," stated Eun-Jig Lee and colleagues from Northwestern University, Illinois. "The human growth hormone (GH) promoter sequences (-610, +58) were inserted into adenovirus type 5 DNA so as to drive the E1a gene (AdGHE1a)."
Lee et al. presented data from their study at the ENDO 2000 conference, Shaping the Future of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.